STRADA Gene Polyhydramnios Megalencephaly and Symptomatic Epilepsy NGS Genetic DNA Test
Introduction
The STRADA Gene Polyhydramnios Megalencephaly and Symptomatic Epilepsy NGS Genetic DNA Test is a cutting-edge diagnostic tool designed to identify genetic mutations associated with severe developmental disorders. Utilizing Next Generation Sequencing (NGS) technology, this test plays a pivotal role in understanding the underlying genetic factors contributing to conditions such as megalencephaly and symptomatic epilepsy, which can significantly impact a child’s development and quality of life.
What the Test Measures
This genetic test analyzes the STRADA gene, which is implicated in various dysmorphologies and neurological conditions. By examining the DNA, the test can detect mutations that may lead to polyhydramnios, megalencephaly, and epilepsy, providing valuable insights for clinicians and families.
Who Should Consider This Test
Patients exhibiting symptoms such as:
- Abnormal brain development (megalencephaly)
- Severe neurological symptoms (epilepsy)
- Polyhydramnios during pregnancy
Additionally, individuals with a family history of similar conditions or those who have undergone genetic counseling should consider this test for a comprehensive genetic evaluation.
Benefits of Taking the Test
- Identifies genetic causes of developmental disorders.
- Provides essential information for effective management and treatment options.
- Facilitates informed family planning and genetic counseling.
- Helps in understanding the prognosis of the affected individual.
Understanding Your Results
Results from the STRADA Gene Polyhydramnios Megalencephaly and Symptomatic Epilepsy NGS Genetic DNA Test will typically be available within 3 to 4 weeks. A genetic counselor or healthcare provider will help interpret the findings, providing clarity on the implications of the results for the patient and their family.
Test Pricing
| Test Name | Discount Price | Regular Price |
|---|---|---|
| STRADA Gene Polyhydramnios Megalencephaly and Symptomatic Epilepsy NGS Genetic DNA Test | 40000 KSh | 56000 KSh |
Convenient Access Across Kenya
We have branches across major cities in Kenya, including Nairobi, Mombasa, and Kisumu, making it easy for you to access this vital test. Additionally, we offer home sample collection services for your convenience.
Book Your Test Today!
Don’t wait to gain crucial insights into your health. Book the STRADA Gene Polyhydramnios Megalencephaly and Symptomatic Epilepsy NGS Genetic DNA Test today! For inquiries or to schedule your test, call or WhatsApp us at +254711564616.
